Effetto di levetiracetam endovena sulle anomalie epilettiformi intercritiche in pazienti con epilessia parziale

C. Varrasi; M. Mula; G. Strigaro; P. Prandi; F. Monaco; R. Cantello

Effetto di levetiracetam endovena sulle anomalie epilettiformi intercritiche in pazienti con epilessia parziale

Translated title of the contribution: The effect of levetiracetam intravenous on interictal epileptiform abnormalities in patients with focal epilepsy

C. Varrasi
, M. Mula
, G. Strigaro
, P. Prandi
, F. Monaco
, R. Cantello

Department of Translational Medicine

Research output: Contribution to journal › Article › peer-review

Abstract

Levetiracetam (LEV) is one of the newly introduced antiepileptic drugs (AEDs) that showed to be effective in the monotherapy of partial with and without secondarily generalized seizures. We report on the effect of the intravenous administration of LEV on interictal epileptiform abnormalities (IEAs) in patients with symptomatic focal epilepsy. In the majority of patients we observed a 50% reduction of IEAs in terms of frequency, duration and scalp distribution. Intravenous LEV showed to be effective and well tolerated.

Translated title of the contribution	The effect of levetiracetam intravenous on interictal epileptiform abnormalities in patients with focal epilepsy
Original language	Italian
Pages (from-to)	185-187
Number of pages	3
Journal	Bollettino - Lega Italiana contro l'Epilessia
Issue number	140
Publication status	Published - Apr 2010

Cite this

@article{d34b11f227734761a674bfed97c1395e,

title = "Effetto di levetiracetam endovena sulle anomalie epilettiformi intercritiche in pazienti con epilessia parziale",

abstract = "Levetiracetam (LEV) is one of the newly introduced antiepileptic drugs (AEDs) that showed to be effective in the monotherapy of partial with and without secondarily generalized seizures. We report on the effect of the intravenous administration of LEV on interictal epileptiform abnormalities (IEAs) in patients with symptomatic focal epilepsy. In the majority of patients we observed a 50\% reduction of IEAs in terms of frequency, duration and scalp distribution. Intravenous LEV showed to be effective and well tolerated.",

keywords = "Epilepsy, Interictal epileptiform abnormalities, Intravenous, Levetiracetam",

author = "C. Varrasi and M. Mula and G. Strigaro and P. Prandi and F. Monaco and R. Cantello",

year = "2010",

month = apr,

language = "Italian",

pages = "185--187",

journal = "Bollettino - Lega Italiana contro l'Epilessia",

issn = "0394-560X",

publisher = "Lega Italiana contro l'Epilessia",

number = "140",

}

TY - JOUR

T1 - Effetto di levetiracetam endovena sulle anomalie epilettiformi intercritiche in pazienti con epilessia parziale

AU - Varrasi, C.

AU - Mula, M.

AU - Strigaro, G.

AU - Prandi, P.

AU - Monaco, F.

AU - Cantello, R.

PY - 2010/4

Y1 - 2010/4

N2 - Levetiracetam (LEV) is one of the newly introduced antiepileptic drugs (AEDs) that showed to be effective in the monotherapy of partial with and without secondarily generalized seizures. We report on the effect of the intravenous administration of LEV on interictal epileptiform abnormalities (IEAs) in patients with symptomatic focal epilepsy. In the majority of patients we observed a 50% reduction of IEAs in terms of frequency, duration and scalp distribution. Intravenous LEV showed to be effective and well tolerated.

AB - Levetiracetam (LEV) is one of the newly introduced antiepileptic drugs (AEDs) that showed to be effective in the monotherapy of partial with and without secondarily generalized seizures. We report on the effect of the intravenous administration of LEV on interictal epileptiform abnormalities (IEAs) in patients with symptomatic focal epilepsy. In the majority of patients we observed a 50% reduction of IEAs in terms of frequency, duration and scalp distribution. Intravenous LEV showed to be effective and well tolerated.

KW - Epilepsy

KW - Interictal epileptiform abnormalities

KW - Intravenous

KW - Levetiracetam

UR - https://www.scopus.com/pages/publications/77953102087

M3 - Articolo in rivista

AN - SCOPUS:77953102087

SN - 0394-560X

SP - 185

EP - 187

JO - Bollettino - Lega Italiana contro l'Epilessia

JF - Bollettino - Lega Italiana contro l'Epilessia

IS - 140

ER -

Effetto di levetiracetam endovena sulle anomalie epilettiformi intercritiche in pazienti con epilessia parziale

Abstract

Other files and links

Fingerprint

Cite this